Dr David Simpson

MB ChB 1987 Auckland; FRACP 1996; FRCPA 1996

David is a Haematologist with extensive interest in malignant haematology. David qualified and specialised in Auckland and completed postgraduate training in Vancouver and Toronto. He was Assistant Professor of Bone Marrow Transplant and Cell Therapy at Rush Cancer Institute in Chicago. David has authored a number of journal articles, reviews, and abstracts along with being the principal investigator in over 60 trials in clinical research. He is an internationally recognised expert in Multiple Myeloma, CLL and Castlemans disease, and is a member of The Castlemans Disease Collaborative Network (CDCN) Scientific Advisory Committee, the Australasian Myeloma Scientific Advisory Group (MSAG). He is a trustee of Myeloma New Zealand. David is also a member of the Pharmacy and Therapeutics Committee at North Shore Hospital and the Tender Subcommittee of PHARMAC. David continues to provide expert commentary for New Zealand’s Lymphoma and Leukaemia Research Review and Multiple Myeloma Research Review. David is also a member of the Pharmacy and Therapeutics Committee at North Shore Hospital and the Tender Subcommittee of PHARMAC.

• malignant and non-malignant haematology
• Lymphoma
• Leukaemia
• Myeloma
• Iron Deficiency